Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosuppressive Signatures in Cervical Cancer
NCT02875990Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Sep 2016
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Lack of tumor emboli histological analysis at 60 months. Status: unknown.
Beyond the preview
Go deeper on NCT02875990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875990.